Patents by Inventor Chenggang LU

Chenggang LU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • WNT surrogate molecules and uses thereof
    Patent number: 11773171
    Abstract: The present invention provides Wnt pathway agonists and related compositions, which may be used in any of a variety of therapeutic methods for the treatment of diseases.
    Type: Grant
    Filed: December 19, 2018
    Date of Patent: October 3, 2023
    Assignee: Surrozen Operating, Inc.
    Inventors: Yang Li, Tom Zhiye Yuan, Aaron Ken Sato, Wen-Chen Yeh, Claudia Yvonne Janda, Tristan William Fowler, Helene Baribault, Kuo-Pao Lai, Liqin Xie, Randall J. Brezski, Chenggang Lu
  • MODULATION OF WNT SIGNALING IN GASTROINTESTINAL DISORDERS
    Publication number: 20220195053
    Abstract: The present invention provides methods of treating gastrointestinal disorders with modulators of the WNT signaling pathway. Also provided are methods of dosing and pharmaceutical compositions.
    Type: Application
    Filed: March 11, 2020
    Publication date: June 23, 2022
    Applicant: Surrozen Operating Inc.
    Inventors: Yang LI, Chenggang LU, Hélène BARIBAULT, Wen-Chen YEH, Liqin XIE, I-Chieh WANG, Weixu MENG
  • ANTI-FRIZZLED ANTIBODIES AND METHODS OF USE
    Publication number: 20210087280
    Abstract: The present invention provides anti-Fzd monoclonal antibodies and related compositions, which may be used in any of a variety of therapeutic methods for the treatment of diseases.
    Type: Application
    Filed: December 19, 2018
    Publication date: March 25, 2021
    Inventors: Yang LI, Tom Zhiye YUAN, Aaron Ken SATO, Wen-Chen YEH, Chenggang LU, Parthasarathy SAMPATHKUMAR, Claudia Yvonne JANDA
  • WNT SURROGATE MOLECULES AND USES THEREOF
    Publication number: 20200308287
    Abstract: The present invention provides Wnt pathway agonists and related compositions, which may be used in any of a variety of therapeutic methods for the treatment of diseases.
    Type: Application
    Filed: December 19, 2018
    Publication date: October 1, 2020
    Inventors: Yang LI, Tom Zhiye YUAN, Aaron Ken SATO, Wen-Chen YEH, Claudia Yvonne JANDA, Tristan William FOWLER, Helene BARIBAULT, Kuo-Pao LAI, Liqin XIE, Randall J. BREZSKI, Chenggang LU
  • CPU SCHEDULING METHOD, TERMINAL DEVICE AND PROCESSING DEVICE
    Publication number: 20160266929
    Abstract: The present invention discloses a CPU scheduling method, apparatus, and system based on a heterogeneous multi-core system, relates to the technical field of CPU scheduling of a computer system, and is used for implementing CPU scheduling for the heterogeneous multi-core system, properly using resources, improving system performance, and giving full play to advantages of the heterogeneous multi-core system. The CPU scheduling method based on a heterogeneous multi-core system includes: receiving performance type information that is of an application program and sent by a processing device; and scheduling a CPU for the application program according to the performance type information of the application program.
    Type: Application
    Filed: May 20, 2016
    Publication date: September 15, 2016
    Applicant: HUAWEI TECHNOLOGIES CO., LTD.
    Inventor: Chenggang LU